Endogenous Interleukin 6 Conveys Resistance to cis-Diamminedichloroplatinum-Mediated Apoptosis of the K562 Human Leukemic Cell Line
Authors:
- George V.Z. DedoussisGDGeorge V.Z. Dedoussis
- Athanasia MouzakiAMAthanasia Mouzaki
- Maria TheodoropoulouMTMaria Theodoropoulou
- Panagiotis MenounosPMPanagiotis Menounos
- Marie-Christine KyrtsonisMKMarie-Christine Kyrtsonis
- Andreas KaramerisAKAndreas Karameris
- Alice ManiatisAMAlice Maniatis
- 1 June 1999
- journal article
- Published by Elsevier in Experimental Cell Research
- Vol. 249 (2) , 269-278
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Interleukin-6 in Biology and Medicine1993
- AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6.Proceedings of the National Academy of Sciences, 1990
- Analysis of Events Associated With Cell Cycle Arrest at G2 Phase and Cell Death Induced by CisplatinJNCI: Journal of the National Cancer Institute, 1990
- A possible autocrine role for interleukin-6 in two lymphoma cell linesBlood, 1989
- Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomasNature, 1988
- Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells.Proceedings of the National Academy of Sciences, 1987
- Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulinNature, 1986
- CisplatinAnnals of Internal Medicine, 1984
- Cell Death: The Significance of Apoptosis1980
- The Mechanism of Action of Antitumor Platinum Compounds1979